Methods for inducing an immune response by administering activated mesenchymal stem cells
AssigneeRutgers, The State University of New Jersey
InventorsYufang Shi, Guangwen Ren, Liying Zhang
Life of this patent
Estimating the term…
Abstract
The present invention provides methods or kits with inflammatory cytokines to pretreat 1-ISCs to augment their immune modulatory effect, in prevention and treatment of various diseases such as multiple sclerosis, arthritis, lupus, sepsis, hepatitis, cirrhosis, Parkinson's disease, chronic infections, and GvHD. The present invention relates to novel methods for enhancing the immunosuppressive or the immune stimulatory activities of mesenchymal stem cells (JvfSCs).
Claims3
A method for inducing an immune response in a patient in need thereof comprising administering to said patient an effective amount of:
- (a) a population of isolated trained mesenchymal stem cells;
- (b) isolated IFNγ;
- and
- (c) an effective amount of at least one cytokine for inducing an immune response, the at least one cytokine selected from the group consisting of interleukin-1 alpha (IL-1 α), interleukin-1 beta (IL-1 β), Type 1 interferon alpha (IFN-I α), Type 1 interferon beta (IFN-I β), tumor necrosis factor alpha (TNF α), transforming growth factor beta (TGF β), and fibroblast growth factor (FGF).
A method of inducing an immune response comprising administering to a subject in need thereof an effective amount of a population of isolated trained mesenchymal stem cells prepared by a process comprising the steps of:
- (i) obtaining multipotent progenitor cells;
- (ii) culturing said multipotent progenitor cells in a medium;
- (iii) separating mesenchymal stem cells from differentiated cells in said medium;
- and
- (iv) activating at least a subset of said separated mesenchymal stem cells by exposing it to isolated IFNγ and an effective amount of at least one cytokine for inducing an immune response, the at least one cytokine selected from the group consisting of IL-1 α, IL-1 β, IFN-I α, IFN-I β, TNF α, TGF β, and FGF for a sufficient period of time such that the activated mesenchymal stem cells are immunomodulatory.
A method for inducing an immune response in a patient in need thereof comprising administering to said patient a composition comprising an effective amount of a population of isolated trained mesenchymal stem cells activated by exposure to IFNγ and an effective amount of at least one cytokine for inducing an immune response, the at least one cytokine selected from the group consisting of IL-1 α, IL-1 β, TNF α, IFN-I α, IFN-I β, TGF β, and FGF for sufficient amount of time for a sufficient period of time such that the activated mesenchymal stem cells are immunomodulatory.
Dependencies are inferred from the claim text.